Showing results (2401-2410 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|February 27, 2020
Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastomaLata Singh, Mithalesh Kumar Singh, Moshahid Alam Rizvi, et al.Cancer Immunology, Immunotherapy : CII|February 28, 2020
Myeloid-derived suppressor cells impede T cell functionality and promote Th17 differentiation in oral squamous cell carcinomaAsif A Dar, Rushikesh S Patil, Trupti N Pradhan, et al.Cancer Immunology, Immunotherapy : CII|March 5, 2020
Less is more: reducing the number of administered chimeric antigen receptor T cells in a mouse model using a mathematically guided approachAnat Globerson Levin, Natalie Kronik, Tamar Shiloach, et al.Cancer Immunology, Immunotherapy : CII|March 5, 2020
Current progress in NK cell biology and NK cell-based cancer immunotherapyRaquel Tarazona, Nelson Lopez-Sejas, Beatriz Guerrero, et al.Cancer Immunology, Immunotherapy : CII|March 7, 2020
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohortAbdul Rafeh Naqash, Biagio Ricciuti, Dwight H Owen, et al.Cancer Immunology, Immunotherapy : CII|March 2, 2020
Neutrophils are mediators of metastatic prostate cancer progression in boneDiane L Costanzo-Garvey, Tyler Keeley, Adam J Case, et al.Cancer Immunology, Immunotherapy : CII|March 22, 2020
TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patientsMaya Dadiani, Daniela Necula, Smadar Kahana-Edwin, et al.Cancer Immunology, Immunotherapy : CII|March 21, 2020
Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic targetSaid Farschtschi, Lan Kluwe, Su-Jin Park, et al.Cancer Immunology, Immunotherapy : CII|March 23, 2020
Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancerRuochen Li, Heng Zhang, Yifan Cao, et al.Cancer Immunology, Immunotherapy : CII|March 15, 2020
Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomesAsmaa M Zahran, Helal F Hetta, Amal Rayan, et al.Pageof 652